Cardax, Inc.

Nov 13, 2020

Cardax Reports Q3 2020 Results

May 15, 2020

Cardax Reports Q1 2020 Results

Mar 30, 2020

Cardax Reports 2019 Annual Results

Jan 14, 2020

Cardax, Inc. Announces Reverse Stock Split of Common Stock

Nov 14, 2019

Cardax Reports Q3 2019 Results

Sep 23, 2019

Cardax Announces Interim Results from CHASE Clinical Trial

Aug 14, 2019

Cardax Files Registration Statement for Proposed $15 Million Follow-On Offering

Mar 28, 2019

Cardax Reports 2018 Results

Jan 25, 2019

Cardax to Present at NobleCon XV

Nov 28, 2018

Cardax Names Former Amarin Head of Development Paresh N. Soni, MD, PhD, to lead Clinical and Regulatory Strategy

Nov 13, 2018

Cardax Reports Q3 2018 Results

Oct 02, 2018

Cardax Launches Human Clinical Trial Targeting Cardiovascular Inflammatory Health

Jul 30, 2018

Cardax Announces Successful Completion of Warrant Exchange Offer

Jun 22, 2018

Cardax Announces Effectiveness of Registration Statement and Commencement of Warrant Exchange Offer

Jun 13, 2018

Cardax Engages Industry Veteran Fred Sancilio, Ph.D., to Launch Orphan Drug Development Program

Jun 01, 2018

Cardax Adds Makarand Jawadekar, Ph.D., and Elona Kogan to its Board of Directors

May 02, 2018

Cardax Announces Warrant Exchange Offer

Mar 27, 2018

Cardax Reports 2017 Results

Dec 05, 2017

Cardax Refutes Allegations by Competitive Trade Group, NAXA

Nov 14, 2017

Cardax Reports Q3 2017 Results